This invention relates to methods by which a predisposition to cancer can be determined. In particular, it relates to methods for detecting whether a patient has a predisposition to cancer, particularly hereditary diffuse gastric cancer with reference to an alteration (mutation) in the gene encoding E-cadherin.
展开▼